These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38330258)

  • 21. Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1.
    Elsby R; Hare V; Neal H; Outteridge S; Pearson C; Plant K; Gill RU; Butler P; Riley RJ
    Drug Metab Dispos; 2019 Jan; 47(1):1-8. PubMed ID: 30348903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism-Based Inactivation of Cytochrome P450 3A4 by Benzbromarone.
    Tang LWT; Verma RK; Fan H; Chan ECY
    Mol Pharmacol; 2021 Apr; 99(4):266-276. PubMed ID: 33436520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract.
    Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
    Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chelerythrine induces apoptosis via ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human renal cell carcinoma.
    He H; Zhuo R; Dai J; Wang X; Huang X; Wang H; Xu D
    J Cell Mol Med; 2020 Jan; 24(1):50-60. PubMed ID: 31568643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique.
    Stiborová M; Simánek V; Frei E; Hobza P; Ulrichová J
    Chem Biol Interact; 2002 Aug; 140(3):231-42. PubMed ID: 12204579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme.
    Henne KR; Tran TB; VandenBrink BM; Rock DA; Aidasani DK; Subramanian R; Mason AK; Stresser DM; Teffera Y; Wong SG; Johnson MG; Chen X; Tonn GR; Wong BK
    Drug Metab Dispos; 2012 Jul; 40(7):1429-40. PubMed ID: 22517972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of chelerythrine against ethanol-induced gastric ulcer in mice.
    Li WF; Hao DJ; Fan T; Huang HM; Yao H; Niu XF
    Chem Biol Interact; 2014 Feb; 208():18-27. PubMed ID: 24300194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Br J Pharmacol; 2012 Apr; 165(8):2787-98. PubMed ID: 22014153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4.
    Rock BM; Hengel SM; Rock DA; Wienkers LC; Kunze KL
    Mol Pharmacol; 2014 Dec; 86(6):665-74. PubMed ID: 25274602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity.
    Shen Q; Zuo M; Ma L; Tian Y; Wang L; Jiang H; Zhou Q; Zhou H; Yu L; Zeng S
    Chem Biol Interact; 2014 Dec; 224():89-99. PubMed ID: 25451576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
    Loos NHC; Beijnen JH; Schinkel AH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells.
    Tang ZH; Cao WX; Wang ZY; Lu JH; Liu B; Chen X; Lu JJ
    Redox Biol; 2017 Aug; 12():367-376. PubMed ID: 28288416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Reversible and Irreversible Interactions between Benzbromarone and Human Cytochrome P450s 3A4 and 3A5.
    Tang LWT; Verma RK; Yong RP; Li X; Wang L; Lin Q; Fan H; Chan ECY
    Mol Pharmacol; 2021 Sep; 100(3):224-236. PubMed ID: 34210765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug-drug interactions.
    Masamrekh RA; Kuzikov AV; Haurychenka YI; Shcherbakov KA; Veselovsky AV; Filimonov DA; Dmitriev AV; Zavialova MG; Gilep AA; Shkel TV; Strushkevich NV; Usanov SA; Archakov AI; Shumyantseva VV
    Fundam Clin Pharmacol; 2020 Feb; 34(1):120-130. PubMed ID: 31286572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone.
    Hong Y; Chia YM; Yeo RH; Venkatesan G; Koh SK; Chai CL; Zhou L; Kojodjojo P; Chan EC
    Mol Pharmacol; 2016 Jan; 89(1):1-13. PubMed ID: 26490246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sanguinarine and chelerythrine as inhibitors of aromatic amino acid decarboxylase.
    Drsata J; Ulrichová J; Walterová D
    J Enzyme Inhib; 1996; 10(4):231-237. PubMed ID: 8872743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines.
    Sedo A; Malík R; Vicar J; Simánek V; Ulrichová J
    Physiol Res; 2003; 52(3):367-72. PubMed ID: 12790770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity.
    Lim SYM; Binti Azidin AR; Ung YT; Al-Shagga M; Alshawsh MA; Mohamed Z; Ong CE; Pan Y
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):423-431. PubMed ID: 30306496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G.
    Xiaoyang L; Chenming N; Chengqing L; Tao L
    Afr Health Sci; 2015 Jun; 15(2):590-3. PubMed ID: 26124807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.